Literature DB >> 26415122

Cross Talk in HEK293 Cells Between Nrf2, HIF, and NF-κB Activities upon Challenges with Redox Therapeutics Characterized with Single-Cell Resolution.

Katarina Johansson1, Marcus Cebula1, Olle Rengby1, Kristian Dreij2, Karl E Carlström3, Kristmundur Sigmundsson4, Fredrik Piehl3, Elias S J Arnér1.   

Abstract

AIM: Many transcription factors with importance in health and disease are redox regulated. However, how their activities may be intertwined in responses to redox-perturbing stimuli is poorly understood. To enable in-depth characterization of this aspect, we here developed a methodology for simultaneous determination of nuclear factor E2-related factor 2 (Nrf2), hypoxia-inducible factor (HIF), and nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) activation at single-cell resolution, using a new tool named pTRAF (plasmid for transcription factor reporter activation based upon fluorescence). The pTRAF allowed determination of Nrf2, HIF, and NF-κB activities in a high-resolution and high-throughput manner, and we here assessed how redox therapeutics affected the activities of these transcription factors in human embryonic kidney cells (HEK293).
RESULTS: Cross talk was detected between the three signaling pathways upon some types of redox therapeutics, also by using inducers typically considered specific for Nrf2, such as sulforaphane or auranofin, hypoxia for HIF activation, or tumor necrosis factor alpha (TNFα) for NF-κB stimulation. Doxorubicin, at low nontoxic doses, potentiated TNFα-induced activation of NF-κB and HIF, without effects in stand-alone treatment. Stochastic activation patterns in cell cultures were also considerable upon challenges with several redox stimuli. INNOVATION: A novel strategy was here used to study simultaneous activation of Nrf2, HIF, and NF-κB in single cells. The method can also be adapted for studies of other transcription factors.
CONCLUSION: The pTRAF provides new opportunities for in-depth studies of transcription factor activities. In this study, we found that upon challenges of cells with several redox-perturbing conditions, Nrf2, HIF, and NF-κB are uniquely responsive to separate stimuli, but can also display marked cross talk to each other within single cells. Antioxid. Redox Signal. 26, 229-246.

Entities:  

Keywords:  HIF; NF-κB; Nrf2; pTRAF; redox regulation; transcription factors

Mesh:

Substances:

Year:  2015        PMID: 26415122      PMCID: PMC5704776          DOI: 10.1089/ars.2015.6419

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  46 in total

1.  Human placenta thioredoxin reductase: preparation and inhibitor studies.

Authors:  Stephan Gromer; Heiko Merkle; R Heiner Schirmer; Katja Becker
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

Review 2.  Redox activation of Nrf2 & NF-κB: a double end sword?

Authors:  Mabel Buelna-Chontal; Cecilia Zazueta
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

Review 3.  A guide to choosing fluorescent proteins.

Authors:  Nathan C Shaner; Paul A Steinbach; Roger Y Tsien
Journal:  Nat Methods       Date:  2005-12       Impact factor: 28.547

Review 4.  Redox regulation of NF-kappa B activation.

Authors:  L Flohé; R Brigelius-Flohé; C Saliou; M G Traber; L Packer
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

5.  Single-cell RNA-seq reveals dynamic, random monoallelic gene expression in mammalian cells.

Authors:  Qiaolin Deng; Daniel Ramsköld; Björn Reinius; Rickard Sandberg
Journal:  Science       Date:  2014-01-10       Impact factor: 47.728

6.  TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.

Authors:  A H V Remels; H R Gosker; K J P Verhees; R C J Langen; A M W J Schols
Journal:  Endocrinology       Date:  2015-02-24       Impact factor: 4.736

Review 7.  Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.

Authors:  Elias S J Arnér
Journal:  Biochim Biophys Acta       Date:  2009-02-11

8.  Glutathione- and thioredoxin-related enzymes are modulated by sulfur-containing chemopreventive agents.

Authors:  Ying Hu; Sabine Urig; Sasa Koncarevic; Xinjiang Wu; Marina Fischer; Stefan Rahlfs; Volker Mersch-Sundermann; Katja Becker
Journal:  Biol Chem       Date:  2007-10       Impact factor: 3.915

Review 9.  Signal transduction by reactive oxygen species.

Authors:  Toren Finkel
Journal:  J Cell Biol       Date:  2011-07-11       Impact factor: 10.539

10.  Homophilic adhesion and CEACAM1-S regulate dimerization of CEACAM1-L and recruitment of SHP-2 and c-Src.

Authors:  Mario M Müller; Esther Klaile; Olga Vorontsova; Bernhard B Singer; Björn Obrink
Journal:  J Cell Biol       Date:  2009-11-16       Impact factor: 10.539

View more
  14 in total

Review 1.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

2.  Creation of a synthesis-friendly inflammation-inducible promoter suitable for cell therapy.

Authors:  Anish Jadav; Kevin Truong
Journal:  Integr Biol (Camb)       Date:  2021-10-15       Impact factor: 3.177

3.  Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors.

Authors:  Erica Miraglia; Frank Nylén; Katarina Johansson; Elias Arnér; Marcus Cebula; Susan Farmand; Håkan Ottosson; Roger Strömberg; Gudmundur H Gudmundsson; Birgitta Agerberth; Peter Bergman
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

4.  Time- and cell-resolved dynamics of redox-sensitive Nrf2, HIF and NF-κB activities in 3D spheroids enriched for cancer stem cells.

Authors:  Anna P Kipp; Stefanie Deubel; Elias S J Arnér; Katarina Johansson
Journal:  Redox Biol       Date:  2017-03-10       Impact factor: 11.799

5.  Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.

Authors:  Karl E Carlström; Ewoud Ewing; Mathias Granqvist; Alexandra Gyllenberg; Shahin Aeinehband; Sara Lind Enoksson; Antonio Checa; Tejaswi V S Badam; Jesse Huang; David Gomez-Cabrero; Mika Gustafsson; Faiez Al Nimer; Craig E Wheelock; Ingrid Kockum; Tomas Olsson; Maja Jagodic; Fredrik Piehl
Journal:  Nat Commun       Date:  2019-07-12       Impact factor: 14.919

6.  Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin.

Authors:  Amir Ata Saei; Hjalmar Gullberg; Pierre Sabatier; Christian M Beusch; Katarina Johansson; Bo Lundgren; Per I Arvidsson; Elias S J Arnér; Roman A Zubarev
Journal:  Redox Biol       Date:  2020-03-03       Impact factor: 11.799

Review 7.  Time in Redox Adaptation Processes: From Evolution to Hormesis.

Authors:  Mireille M J P E Sthijns; Antje R Weseler; Aalt Bast; Guido R M M Haenen
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923

8.  Sulforaphane Improves Ischemia-Induced Detrusor Overactivity by Downregulating the Enhancement of Associated Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Rat Bladder.

Authors:  Huai-Ching Tai; Shiu-Dong Chung; Chiang-Ting Chien; Hong-Jeng Yu
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

9.  Cytotoxicity of portoamides in human cancer cells and analysis of the molecular mechanisms of action.

Authors:  Tiago Ribeiro; Filipa Lemos; Marco Preto; Joana Azevedo; Maria Lígia Sousa; Pedro N Leão; Alexandre Campos; Stig Linder; Rui Vitorino; Vitor Vasconcelos; Ralph Urbatzka
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

10.  Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia.

Authors:  Sara Petrillo; Emanuela Piermarini; Anna Pastore; Gessica Vasco; Tommaso Schirinzi; Rosalba Carrozzo; Enrico Bertini; Fiorella Piemonte
Journal:  Int J Mol Sci       Date:  2017-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.